佳利律师事务所积极代表诸多世界最大规模的生物技术及制药公司处理公司交易事务及标志性的反垄断、监管、仲裁及诉讼事宜。本所亦担任金融机构的法律顾问，协助这些公司进行资本市场融资并为其提供法律咨询。借助全球各地的12处一体化办公室，本所律师代表客户勤勉工作，以跨越疆界并引领遵守跨司法管辖区的监管要求，促成符合客户商业目标的兼并、收购、合营及其他公司交易。
本所在该业务领域的亮点包括：
Practice highlights include:
-
Regular EC law counsel to Merck & Co. on a cutting-edge issues, including in precedent-setting European Court of Justice win regarding the interpretation of the World Trade Organization’s Agreement on Trade Related Aspects of Intellectual Property Rights and in antitrust challenges by generic companies.
- Antitrust counsel to GlaxoSmithKline in connection with numerous transactions, including its recent $15 billion bid to acquire Pfizer’s consumer health care business.
- Counsel to Boehringer Ingelheim in precedent-setting European Court of Justice win regarding the scope of trademark owners’ rights in relation to parallel importers that repackage pharmaceutical products.
- Regular counsel to Medtronic on a range of matters, including in its $3.9 billion Kyphon acquisition.
- Counsel to TPG, Blackstone, Goldman Sachs and KKR in $10.9 billion Biomet acquisition—one of the largest LBOs of all time.
- Antitrust counsel to Merck & Co. in its collaboration with GTx to advance research and development of selective androgen receptor modulators (SARM).
- Regular global counsel to 3M, including in the sale of its global pharmaceuticals business to three buyers.
- Counsel to GlaxoSmithKline in many litigation matters, including a class action litigation in U.S. federal court relating to allegations of patent misuse in connection with Augmentin, GSK’s drugs for treating HIV/AIDS; a U.S. class action challenging GSK’s efforts to restrict illegal export and price-fixing of its products; the simultaneous resolution of a number of pending actions related to Wellbutrin XL; as well as on antitrust issues arising from the settlement of a patent litigation involving Paxil.
- Counsel to GlaxoSmithKline and its U.S. subsidiary SmithKline Beecham in the $1.65 billion acquisition of Reliant Pharmaceuticals, as well as to GSK in its acquisitions of Domantis Limited, Praecis Pharmaceuticals, CNS, ID Biomedical Corporation and Corixa.
- Counsel to Lundbeck in connection with the distribution of pharmaceutical products in Europe.